Free Trial

Integer (ITGR) Competitors

$121.85
+0.40 (+0.33%)
(As of 09:56 AM ET)

ITGR vs. PODD, TFX, GMED, MASI, IART, ATEC, ATRC, OFIX, SRDX, and ANGO

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Insulet (PODD), Teleflex (TFX), Globus Medical (GMED), Masimo (MASI), Integra LifeSciences (IART), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

Integer vs.

Integer (NYSE:ITGR) and Insulet (NASDAQ:PODD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking.

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.60B2.56$90.65M$2.8942.16
Insulet$1.70B7.21$206.30M$3.3052.95

Integer has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Insulet has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.

Integer currently has a consensus price target of $128.00, suggesting a potential upside of 5.47%. Insulet has a consensus price target of $239.18, suggesting a potential upside of 38.85%. Given Insulet's stronger consensus rating and higher possible upside, analysts plainly believe Insulet is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Insulet
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, Insulet had 11 more articles in the media than Integer. MarketBeat recorded 14 mentions for Insulet and 3 mentions for Integer. Insulet's average media sentiment score of 1.12 beat Integer's score of 0.83 indicating that Insulet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Insulet
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Insulet has a net margin of 13.14% compared to Integer's net margin of 6.01%. Insulet's return on equity of 34.06% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.01% 11.25% 5.69%
Insulet 13.14%34.06%9.08%

Insulet received 337 more outperform votes than Integer when rated by MarketBeat users. Likewise, 66.08% of users gave Insulet an outperform vote while only 63.41% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
376
63.41%
Underperform Votes
217
36.59%
InsuletOutperform Votes
713
66.08%
Underperform Votes
366
33.92%

99.3% of Integer shares are owned by institutional investors. 2.0% of Integer shares are owned by company insiders. Comparatively, 0.5% of Insulet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Insulet beats Integer on 15 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$4.07B$3.22B$5.13B$17.46B
Dividend YieldN/A1.68%2.83%3.53%
P/E Ratio41.999.67171.0525.52
Price / Sales2.5570.282,443.5110.11
Price / Cash15.4474.8735.2719.29
Price / Book2.674.335.525.82
Net Income$90.65M$87.88M$105.72M$975.72M
7 Day Performance-0.39%1.22%0.64%-0.51%
1 Month Performance8.74%9.19%2.55%2.67%
1 Year Performance48.11%-5.09%5.38%22.10%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PODD
Insulet
4.9036 of 5 stars
$180.07
+5.4%
$239.44
+33.0%
-36.8%$12.61B$1.70B54.573,000Insider Selling
Short Interest ↑
Positive News
TFX
Teleflex
4.6962 of 5 stars
$206.35
-0.1%
$261.75
+26.8%
-12.8%$9.72B$2.97B33.1214,500Short Interest ↑
GMED
Globus Medical
4.6995 of 5 stars
$65.82
+0.7%
$68.50
+4.1%
+23.3%$8.91B$1.57B102.855,000Analyst Forecast
Short Interest ↓
Analyst Revision
Positive News
MASI
Masimo
4.1876 of 5 stars
$127.00
+1.8%
$138.71
+9.2%
-19.3%$6.74B$1.98B86.395,200Short Interest ↓
Analyst Revision
Positive News
IART
Integra LifeSciences
4.8354 of 5 stars
$28.31
-0.7%
$35.00
+23.6%
-23.0%$2.23B$1.54B56.623,946Positive News
ATEC
Alphatec
4.5636 of 5 stars
$10.12
+0.2%
$22.89
+126.2%
-28.6%$1.42B$482.26M-6.79839Short Interest ↓
Positive News
ATRC
AtriCure
2.5768 of 5 stars
$23.19
+3.3%
$49.78
+114.7%
-53.9%$1.10B$414.60M-28.991,200Positive News
OFIX
Orthofix Medical
0.6336 of 5 stars
$14.89
+0.1%
$18.00
+20.9%
-23.4%$558.82M$746.64M-4.411,634
SRDX
Surmodics
3.1606 of 5 stars
$34.38
+0.5%
$57.00
+65.8%
+138.3%$490.26M$132.58M36.19376Analyst Forecast
News Coverage
Gap Up
ANGO
AngioDynamics
4.5123 of 5 stars
$6.17
+0.8%
$13.25
+114.7%
-34.0%$247.17M$338.75M-1.27815Short Interest ↓
Analyst Revision
News Coverage

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners